Conexiant
Login
  • The Analytical Scientist
  • The Cannabis Scientist
  • The Medicine Maker
  • The Ophthalmologist
  • The Pathologist
  • The Traditional Scientist
The Medicine Maker
  • Explore

    Explore

    • Latest
    • Features
    • Interviews
    • Business & Trends
    • Technology & Manufacturing
    • Product Profiles
    • White Papers

    Featured Topics

    • Biopharma
    • Small Molecules
    • Cell & Gene
    • Future of Pharma

    Issues

    • Latest Issue
    • Archive
    • Cell and Gene Therapy Supplement
  • Topics

    Topics

    • Drug Discovery
    • Development & Clinical
    • Formulation
    • Drug Delivery
    • Bioprocessing
    • Small Molecules
    • Cell and Gene
    • Facilities & Equipment
    • Outsourcing
    • Packaging
    • Supply Chain
    • Regulation & Standards
  • News & Blogs

    News & Blogs

    • Industry News
    • Research News
    • Blogs
  • Events
    • Live Events
    • Webinars
  • Community & Awards

    Community & Awards

    • Power List
    • Sitting Down With
    • Innovation Awards
    • Company of the Year Awards
    • Authors & Contributors
  • Multimedia
    • Video
    • Podcasts
    • eBooks
Subscribe
Subscribe
The Medicine Maker / Issues / 2015 / Articles / Mar / Sustainable Ingredients
Discovery & Development Ingredients

Sustainable Ingredients

By Daniele Piergentili 03/11/2015 1 min read

Share

Climate change, health challenges, and resource inefficiencies or shortages are very high on the agenda of societies around the world. And rightly so – after all, by 2050 nine billion people will share Earth; nine billion who need food, water, energy, housing and medical attention. It is one of the most important tasks of our time to produce high-quality and safe products while saving resources and ensuring quality of life for both today’s and tomorrow’s generation.

Sustainable Solution Steering provides us with a 360-degree view on the sustainability performance of our 50,000-strong portfolio across all industries; it is an essential step in committing and contributing to value chain-specific needs from various industries. BASF has a long history of implementing sustainability initiatives in its organization, but Sustainable Solution Steering goes one step further. It creates the necessary transparency to successfully implement sustainability standards into business activities. After all, if we don’t have a full picture of the sustainability impacts of each product, how can we seek to improve the portfolio as a whole and promote solutions with clear sustainability benefits?

The meaning and focus of sustainability varies from industry to industry, so Sustainable Solutions Steering begins with market needs and industry definition of sustainability and takes industry standards into consideration. For our pharmaceutical industry customers, regulatory aspects and GMP quality standards are important factors. Based on such standards, we then assess each of our products against current and future industry requirements and assign them to one of four categories:

  • Accelerator: substantial sustainability contribution.
  • Performer: meets basic sustainability standards.
  • Transitioner: has a specific sustainability issue, which is being addressed.
  • Challenged: significant sustainability concern identified; action plan in development.

Having started the first pilot workshop in 2011, we have now assessed the company’s entire portfolio involving R&D, product safety, marketing and sales teams. The outcome of the analysis is that many of our Pharma Ingredients & Services products already lie in the Accelerator category and none of them are in the Transitioner or Challenged categories. A good example of an Accelerator product is Kollicoat IR, which is primarily used as a coating excipient for immediate release of drugs from tablets or other solid dosage forms, and allows mixing without the addition of plasticizer. Furthermore, higher coating concentration and higher spray rates significantly reduce the coating time and reduce energy and water consumption in the coating process. Another good example of our continued effort in increasing our number of Accelerator solutions over time is our omega-3 fatty acids portfolio. We have implemented a stringent program to assure that our raw materials come from evaluated sources of healthy fish stocks.

Putting in place our Sustainable Solution Steering approach has been a real journey for us and has helped to harmonize methodologies and understanding of sustainability within the organization. The next major step is to work even more closely with our external partners (customers and suppliers) in order to extract maximum value from our joint effort in the area of sustainability. Sustainability is a journey we can only successfully complete if we work together!

Daniele Piergentili is Vice President, Global Marketing, BASF Health and Nutrition, Florham Park, NJ, USA.

Newsletters

Receive the latest analytical science news, personalities, education, and career development – weekly to your inbox.

Newsletter Signup Image

About the Author(s)

Daniele Piergentili

Daniele Piergentili is Vice President, Global Marketing, BASF Health and Nutrition, Florham Park, NJ, USA.

More Articles by Daniele Piergentili

False

Advertisement

Recommended

False

Related Content

The Long Road to EXCiPACT
Ingredients
The Long Road to EXCiPACT

November 7, 2014

0 min read

If I knew six years ago just how much of my time EXCiPACT would take up, would I have even started? A good question! But, actually, I have no regrets; the story of EXCiPACT and its impact, even today, on the pharmaceutical industry makes every second worthwhile...

SORS and the Power of Light in Pharma
Ingredients Analytical Science Technology and Equipment
SORS and the Power of Light in Pharma

January 17, 2025

7 min read

Understanding the role of spatially offset Raman spectroscopy in identifying raw materials, counterfeit medicines, and more

A DNA-Based Method of Anticounterfeiting
Dosage Forms Drug Delivery Formulation Ingredients
A DNA-Based Method of Anticounterfeiting

December 9, 2024

1 min read

Researchers demonstrate anticounterfeiting method that uses DNA oligos integrated into pharmaceutical products

Who Are the Best Pharma Companies of 2025?
Business Practice Bioprocessing - Upstream & Downstream Contract Development Services Contract Manufacturing Services Small Molecules Ingredients
Who Are the Best Pharma Companies of 2025?

November 6, 2024

1 min read

Which companies in the pharma industry are the best? Categories in The Medicine Maker’s Company of the Year Awards include big pharma, CDMOs, equipment suppliers, and more – and we’re looking for your votes!

The Medicine Maker
Subscribe

About

  • About Us
  • Work at Conexiant Europe
  • Terms and Conditions
  • Privacy Policy
  • Advertise With Us
  • Contact Us

Copyright © 2025 Texere Publishing Limited (trading as Conexiant), with registered number 08113419 whose registered office is at Booths No. 1, Booths Park, Chelford Road, Knutsford, England, WA16 8GS.